AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom
AstraZeneca shares head into Monday’s session under pressure after Nasdaq announced Walmart will take the drugmaker’s spot in the Nasdaq-100 starting Jan. 20.
Nasdaq Nordic Week Ahead: OMXS30 ends February at 3,222.75 as PMIs, inflation and U.S. jobs loom
Friday’s close put Sweden’s OMXS30 at 3,222.75, a 0.55% gain, and that’s the mark Nordic traders will be watching as the new week kicks off. All eyes will be on how data and global risk signals shift sentiment when trading opens Monday.
AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next
AstraZeneca PLC’s U.S.-listed shares will exit the Nasdaq-100 on Jan. 20, with Walmart stepping in as its replacement, Nasdaq announced Friday. Walmart revealed in November plans to shift its listing from the New York Stock Exchange to Nasdaq.
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts
AstraZeneca PLC is a leading Anglo-Swedish pharmaceutical giant specializing in oncology, respiratory, cardiovascular/metabolic, and rare disease medicinesmarketbeat.comastrazeneca.com. Headquartered in Cambridge, UK, it maintains primary listings on the London Stock Exchange and Nasdaq Stockholm, with secondary ADR trading in the U.S.astrazeneca.com. The company was formed in 1999 by merging Sweden’s Astra AB and the UK’s Zeneca. Its 2024 revenues were $54.07 billionastrazeneca.com, driven by top-selling drugs like Tagrisso, Lynparza, Farxiga, and Symbicortmarketbeat.com. In its 2024 Annual Report, AZN describes itself as “a global, science-led, patient-focused pharmaceutical business” and targets $80B in sales by 2030 with at least 20 new drugs launchedastrazeneca.comastrazeneca.com. Current Chair Michel Demaré and CEO Sir Pascal Soriot lead a company with roughly 70–80,000 employees worldwide, strategic R&D hubs in the US, UK, Sweden, China and emerging cell/gene therapy centers.
Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025
The 1 October 2025 session began under a cloud as the federal government shut down due to a budget impasse. Stock futures opened lower amid fears that key economic reports might be delayed investopedia.com. By the closing bell, however, Wall Street had staged a dramatic recovery:
TechStock² Updates
